Acquired von Willebrand syndrome in aortic stenosis

New England Journal of Medicine

Volumn 349, Issue 4, 2003, Pages 343-349

  Vincentelli, André ^a,b   Susen, Sophie ^a,c   Le Tourneau, Thierry ^a,d   Six, Isabelle ^c   Fabre, Olivier ^a,b   Juthier, Francis ^a,b   Bauters, Anne ^a,c   Decoene, Christophe ^b   Goudemand, Jenny ^a,c   Prat, Alain ^a,b   Jude, Brigitte ^a,c,e  

^a UNIV LILLE   (France)

^b Clin de Chirurgie Cardiovasculaire   (France)

^c Inst Hematologie Biol Hemobiol T   (France)

^d Serv Explorations Fonctionnelles C   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MALE; MUCOSAL BLEEDING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; SHEAR STRESS; SKIN BLEEDING; THROMBOCYTE FUNCTION; TREATMENT OUTCOME; VON WILLEBRAND DISEASE; AORTA VALVE STENOSIS; BLEEDING; BLOOD; BLOOD RHEOLOGY; CHEMISTRY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; METABOLISM; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE;

AGED; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMORHEOLOGY; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREVALENCE; QUESTIONNAIRES; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0038793349     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa022831     Document Type: Article

References (26)

1. Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med 1958;259:196.
2. Greenstein RJ, McElhinney AI, Reuben D, Greenstein AJ. Colonic vascular ectasias and aortic stenosis: coincidence or casual relationship? Am J Surg 1986;151:347-51.
3. King RM, Pluth JR, Giuliani ER. The association of unexplained gastrointestinal bleeding with calcific aortic stenosis. Ann Thorac Surg 1987;44:514-6.
4. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet 1992;340:35-7.
5. Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986;67:758-61.
6. Veyradier A, Balian A, Wolf M, et al. Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract. Gastroenterology 2001;120:346-53.
7. Federici AB, Rand JH, Bucciarelli P, et al. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 2000;84:345-9. [Erratum, Thromb Haemost 2000;84:739.]
8. Tsai HM, Sussman II, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994;83:2171-9.
9. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A 1990;87:6306-10.
10. Siediecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996;88:2939-50.
11. Sugimoto M, Matsui H, Mizuno T, et al. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood 2003;101:915-20.
12. Cappell MS, Lebwohl O. Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement. Ann Intern Med 1986;105:54-7.
13. Anderson RP, McGrath K, Street A. Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement. Lancet 1996;347:689-90.
14. Pareti FI, Lattuada A, Bressi C, et al. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000;102:1290-5.
15. Rapaport SI. Preoperative hemostatic evaluation: which tests, if any? Blood 1983;61:229-31.
16. Blery C, Charpak Y, Szatan M, et al. Evaluation of a protocol for selective ordering of preoperative tests. Lancet 1986;1:139-41.
17. Mammen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost 1995;21:Suppl 2:113-21.
18. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998;91:1325-31.
19. Favaloro EJ, Henniker A, Facey D, Hertzberg M. Discrimination of von Willebrand's disease (VWD) subtypes: direct comparison of von willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based von Willebrand factor-capture systems. Thromb Haemost 2000;84:541-7.
20. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980;65:1318-25.
21. Mazurier C. In vitro evaluation of the haemostatic value of the LFB-von Willebrand factor concentrate. Haemophilia 1998;4:Suppl 3:40-3.
22. Zimmerman TS, Dent JA, Ruggeri ZM, et al. Subunit composition of plasma von Willebrand factor: cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID and IIE). J Clin Invest 1986;77:947-51.
23. Veyradier A, Jenkins CS, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost 2000;84:175-82.
24. Warkentin TE, Moore JC, Morgan DG. Gastrointestinal angiodysplasia and aortic stenosis. N Engl J Med 2002;347:858-9.
25. Carabello BA. Aortic stenosis. N Engl J Med 2002;346:677-82.
26. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Heart Valve Dis 1998;7:672-707.